Summit Pharmaceuticals International Corp - Strategic SWOT Analysis Review

November 2021 | 23 pages | ID: S40CE4A010EDEN
GlobalData

Abstracts

Summit Pharmaceuticals International Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – GlobalData’s summarization of the company’s business strategy.
• SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.

Highlights

Summit Pharmaceuticals International Corp (Summit Pharmaceuticals), a subsidiary of Sumitomo Corp, is a pharmaceutical company that markets pharmaceuticals, quasi-drugs and medical devices. It provides drug discovery services, drug discovery instruments and bioresource materials, pharmaceutical development and supply of APIs, intermediates and formulations. The company offers services in research and development assistance to pharmaceutical companies ranging from the assistance with original drug research to the arranging of licensing, production. Summit Pharmaceuticals also imports and exports new drugs and diagnostic products. The company also provides optimal formulations and ingredients to various cosmetics manufacturers. It distributes support tools for drug discovery such as, plants, microorganisms, cells and tissues from animals and chemical library. It also provides consulting services. Summit Pharmaceuticals is headquartered in Chuo-Ku, Tokyo, Japan.

Summit Pharmaceuticals International Corp Key Recent Developments

Sep 30,2021: CytoReason and Summit Pharmaceuticals International announce the introduction of an AI platform to one of Japan's top pharmaceutical companies

Reasons to Buy

• Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
• Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
• Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
• Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

Contents

SECTION 1 - ABOUT THE COMPANY

Summit Pharmaceuticals International Corp - Key Facts
Summit Pharmaceuticals International Corp - Key Employees
Summit Pharmaceuticals International Corp - Major Products and Services
Summit Pharmaceuticals International Corp - History
Summit Pharmaceuticals International Corp - Company Statement
Summit Pharmaceuticals International Corp - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
Summit Pharmaceuticals International Corp - Business Description
Summit Pharmaceuticals International Corp - Corporate Strategy
Summit Pharmaceuticals International Corp - SWOT Analysis
SWOT Analysis - Overview
Summit Pharmaceuticals International Corp - Strengths
Summit Pharmaceuticals International Corp - Weaknesses
Summit Pharmaceuticals International Corp - Opportunities
Summit Pharmaceuticals International Corp - Threats
Summit Pharmaceuticals International Corp - Key Competitors

SECTION 3 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Summit Pharmaceuticals International Corp, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Summit Pharmaceuticals International Corp, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Summit Pharmaceuticals International Corp, Recent Deals Summary

SECTION 4 – COMPANY’S RECENT DEVELOPMENTS

Sep 30, 2021: CytoReason and Summit Pharmaceuticals International announce the introduction of an AI platform to one of Japan's top pharmaceutical companies

SECTION 5 – APPENDIX

Methodology
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

Summit Pharmaceuticals International Corp, Key Facts
Summit Pharmaceuticals International Corp, Key Employees
Summit Pharmaceuticals International Corp, Major Products and Services
Summit Pharmaceuticals International Corp, History
Summit Pharmaceuticals International Corp, Other Locations
Summit Pharmaceuticals International Corp, Key Competitors
Summit Pharmaceuticals International Corp, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Summit Pharmaceuticals International Corp, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Summit Pharmaceuticals International Corp, Recent Deals Summary

List Of Figures

LIST OF FIGURES

Summit Pharmaceuticals International Corp, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Summit Pharmaceuticals International Corp, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021